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Abstract 
Background: Selenium presents anti-inflammatory and antioxidant 
properties which plays a critical role in nutrition of patients following 
devastating conditions. Furthermore, several lines of evidence reported that 
most of patients who admitted to intensive care unit (ICU) have lower plasma 
levels of selenium. Therefore, this study was designed to define the impact of 
selenium supplementation on clinical outcomes of mechanically ventilated 
non-surgical/traumatic critically ill patients.  
Materials and Methods: This study was conducted on 105 subjects 
hospitalized in ICU of Shohadaye Haft-e Tir Hospital, Tehran, Iran. Here the 
acute physiologic assessment and chronic health evaluation (APACHE) II 
score of patients was documented on the day of their ICU admission. The 
patients were divided to two groups based on block randomization technique 
and were assigned to receive selenium or placebo. Then the effect of selenium 
supplementation was evaluated based on the APACHE II score, the 
occurrence of ventilator associated pneumonia (VAP), length of ICU stay and 
the rate of mortality.  
Results: The acquired data revealed no significant difference between two 
experimental groups based on the demographical information. Also it was 
demonstrated that selenium supplementation of critically ill patients was 
associated with better APACHE II score, fewer length of ICU stay and 
fewer mortality rate. Incidence of VAP indicated no significant difference 
between groups.  
Conclusion: The obtained data of this single center clinical trial showed that 
selenium supplementation could improve clinical outcomes of critically ill 
patients.  
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Introduction Critical illnesses are characterized by a life-
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threatening production of reactive oxygen species 
(ROS) and other radical species that lead to oxidative 
stress. Oxidative stress is related to release of 
metalloproteins, copper and iron ions, production of 
nitric oxide and activation of phagocytes (1). It 
established that critical illnesses are accompanied by 
immunosuppression which is correlated with the role 
of ROS (2). Since oxidative stress is associated with 
the severeness of diseases which occurs following the 
elevated level of ROS or declined in antioxidant 
defenses, therefore managing production of ROS is a 
crucial strategy in treating illnesses (3).  
An essential element, selenium, which is found 
in a bunch of proteins calls selenoproteins presents 
anti-inflammatory and antioxidant properties. It has 
been proposed that antioxidant properties of selenium 
are mediated via glutathione peroxidase enzymes 
activation which results in products with less toxicity 
to protect organism against free radicals causing 
oxidative stress (4). Hence, selenium probably plays 
fundamental roles to improve devastating condition 
(5). Nevertheless, in several parts of the world such as 
the Europe and Australasia it has been reported that 
owing to low soil content, peoples are prone to low 
baseline selenium status (6). In addition, a number of 
studies reported that selenium deficiency is common 
among Iranian people (7-10). Furthermore, reduced 
dietary intake, which occurs during critical illnesses, 
can further impair the selenium status. In such 
situation, acute illness combined with selenium 
deficiency might worsen oxidative stress and related 
damages (5, 6). 
Several lines of evidence reported that most of 
patients who admitted to intensive care unit (ICU) 
have lower plasma levels of selenium and glutathione 
peroxidase activity. Moreover, plasma selenium 
concentrations are inversely associated with the 
severity disease (5, 6). Therefore, the aim of the 
present study was to investigate the effects of 
selenium supplementation on clinical outcomes in 
mechanically ventilated, non-surgical and non-





This study was a prospective single center 
clinical trial conducted on 105 subjects hospitalized in 
ICU, Shohadaye Haft-e Tir Hospital (teaching 
hospital of Iran University of medical sciences, 
Tehran, Iran). Patient who signed the written 
informed involved in the study. The investigation was 
carried out in accordance with the declaration of 
Helsinki and approved by the ethics committee of 
Shohadaye Haft-e Tir Hospital.  
The inclusion criteria were patients with age of 
more than 18 years who received mechanical 
ventilation more than 3 days and were admitted to 
ICU due to internal diseases not related to trauma or 
surgery. On the other hand the exclusion criteria were 
patients with renal failure, pancreatitis, short bowel 
syndrome and those that already have pressure ulcers 
and were HIV positive and also had bone marrow, 
lung, kidney and liver transplantation. Also all 
patients who were extubated within two days of 
establishment of mechanical ventilation or those died 
during the study period were excluded from this 
study. 
The information of eligible patients consisting 
the age, gender, cause of hospitalization, diagnosis 
and the acute physiology and chronic health 
evaluation II (APACHE II) score was recorded on the 
day of their admission in the ICU. Moreover, in this 
study the ventilator associated pneumonia (VAP) was 
diagnosed based on Clinical Pulmonary Infection 
Score≥6 (11). In this experiment, patients were 
divided to two groups using block randomization 
technique (12) and assigned to receive selenium 
(group A) or placebo tablets (group B). Patients of 
group A, received one mg selenium as sodium 
selenite pentahydrate at the first day and 0.5 mg 
selenium daily for the following 13 days. 
APACHE II score was calculated in all patients 
of both groups twice: one on the day of their ICU 
admission and, on the 14th day following selenium 
treatment, to define the influence of the selenium 
supplementation at APACHE II score and final 
prognosis. To calculate web based APACHE II score, 
age and 12 relevant physiological variables and 2 
disease related variables used consisting: Glasgow 
Coma score,  white blood cell count, hematocrit, heart 
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and respiratory rate, mean arterial pressure (MAP), 
FiO2 and PaO2, body temperature, arterial pH, serum 
creatinine, serum potassium, serum sodium , the 
occurrence of acute renal failure or severe organ 
system insufficiency and immunocompromised state 
(13). 
Pearson Chi-square test or Fisher’s exact test 
was used to compare categorical data. In addition, 
Student’s t test or Mann–Whitney U test was applied 
to compare continuous variables. A P<0.05 was 
considered statistically significant. 
Results 
Among 250 patients admitted in the ICU, 105 
subjects were eligible to evaluation in this study. 
Here, 55 patients were male while 50 individuals 
were female which randomly divided in two 
experimental groups. One group treated with 
selenium (group A) and the other one received 
placebo (group B) while there was no significant 
difference between two groups based on the age and 
gender of patients. In this investigation, the 
underlying causes of hospitalization in ICU and 
mechanical ventilation evaluated and identified by the 
medical practitioners. In this regard, pulmonary 
diseases were the main reason of hospitalization in 
ICU in both groups that its incidence was about 70%. 
Sepsis was the second cause of these critically ill 
patients’ condition with the prevalence of 14% and 
16% group A and B, respectively. Also based on 
acquired data, 13% of subjects group A and 10% 
group B were admitted to ICU due to central nervous 
system (CNS) disorders (Table 1). Here, the severity 
of illness was defined using APACHE II scoring 
system at the time of their entrance to the ICU.  
In this study statistical analysis of the acquired 
data from the point of interfering factors such as age, 
gender, the cause of hospitalization and illness 
severity revealed no significant difference between 
two experimental groups. According to obtained data 
the average APACHE II score of patients at the 
beginning of their admission to ICU was 20.6±7 and 
21±8 in group A and B, respectively (P= 0.1). 
Following the employed nutritional treatment, the 
APACHE II score of group A reached to 18±3 while 
this score in group B was 19.1±4(P<0.05), which 
shows a significant difference between two groups. 
Based on the APACHE II score, non-operation and 
post-operation predicted mortality percentage of 
patients in both groups were similar; however actual 
mortality in group A was 9 subjects (16.3%) and 12 
subjects (24%) in group B which revealed the 
selenium supplemented nutrition resulted in a 
significant difference in the rate of death between 
groups (P<0.05). The incidence of VAP was another 
factor that has been evaluated between two groups 
that acquired data demonstrated 6 (10.9%) subjects in 
group A were infected while 5 (10%) patients in 
group B developed VAP which indicated no 
significant difference between groups (P=0.3). Also, 
there was a meaningful difference in duration of 
patients’ stay in ICU among groups, as the number of 
days in ICU was 10.1±8 and 11.2±8.2 in group A and 
B, respectively (P<0.05) (Table 2). 
Discussion 
Incidence and cause of malnutrition in ICU are 
multifactorial (14) and loss of essential micronutrients 
is common among critically ill patients who admitted 
to critical care wards. This situation can be worse in 
patients who suffer from micronutrient deficiency 
prior to the illness. Selenium is one of these essential 
trace elements which becomes reduced remarkably 
following devastating conditions (6). Hence, in these 
patients selenium supplementation could be a 
valuable strategy to prevent multi organ dysfunction 
due to severe oxidative stress. The result of this 
prospective randomized and placebo-controlled, 
single-center trial revealed selenium supplementation 
is a critical adjuvant therapeutic approach to improve 
outcome of patients in ICU who were admitted due to 
pulmonary diseases, sepsis or CNS disorders. We 
found that selenium supplementation in mechanically 
ventilated, non-surgical/traumatic adult patients 
during the first days in the ICU was associated with 
better APACHE II score, shorter stay in the ICU and 
fewer rate of death. 
This finding is in agreement with other single 
and multi-center trials which reported the important 
role of this essential trace element in nutrition plan of 
ICU admitted patients. In this regard, Heyland et al. in 
a systematic review on antioxidant supplementations 
reported that enhanced selenium (alone or in 
combination with other antioxidants) can be 
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correlated with decreased rate of mortality (15, 16). 
Also a multiple-center study demonstrated that 
enhanced level of sodium-selenite reduced rate of 
mortality in patients with septic shock or severe sepsis 
(17). In addition, Andrews et al. found that daily 
selenium administration for at least five days, reduced 
new infections (18). On the other hand, Berger et al. 
reported that antioxidant supplements (mixture of 
selenium, zinc, vitamin C and vitamin B1) for 5 days 
did not reduce infectious complications, length of 
hospital stay, early organ failure and mortality; 
however remarkably decreased the inflammatory 
responses in trauma patients or following cardiac 
surgery (19). 
It has been assumed that antioxidant and anti-
inflammatory properties of selenium are mediated 
through glutathione peroxidase and thioredoxin 
reductase which are crucial elements to maintain 
redox system in any types of cells in the body 
including the immune cells (20-22). These two 
enzymes reduce hydrogen peroxide, lipid, and 
phospholipid hydroperoxides and also diminish free 
radicals and ROS propagation (23). Following 
selenium supplementation the selenoprotein is rapidly 
generated which subsequently prevents endothelial 
cells from oxidative damage (24, 25).  
Table 1: Patient characteristics on admission with detail of the diagnostic categories. 
 
Variable   Group A (selenium) Group B (placebo) P value 
Number 55 50  
Age (mean± SD) 47±9 49±8 P>0.05 
Gender   P>0.05 
Male 31 28  
female 24 22  
Illness causing hospitalization    
Pulmonary diseases 38 (69%) 36 (72%)  
Sepsis 8 (14%) 8 (16%)  
CNS disorders 7 (13%) 5 (10%)  
Others 2 (4%) 1 (2%)  
 
Table 2: The effects of selenium supplementation on clinical outcomes of critically ill patients. 
 
Variable   Group A (selenium) Group B (placebo) P value 
Admission APACHE II score  20.6±7 21±8 P<0.05 
Predicted mortality 40/30 % 40/30 %  
Final APACHE II score  18±3 19.1±4  
Actual Mortality (%) 9 (16.3%) 12 (24%) P<0.05 
Length of ICU stay (Days) 10.1±8 11.2±8.2 P<0.05 
VAP Incidence (%) 6 (10.9%) 5 (10%) P>0.05 
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To the best of our knowledge, although so 
many investigations reported the impact of selenium 
supplementation in clinically ill patients in other parts 
of the world, there is just one documented 
investigation in Iran about administration of this trace 
element and its influence on patients who admitted in 
the ICU due to trauma (26). Chelkeba et al. in 2015 
reported the effects of parenteral selenium on 
outcomes of mechanically ventilated patients 
following sepsis, severe sepsis and septic shock and 
their study carried out in a center in Tehran, Iran; 
however, their findings and the target patients were 
different. This research group revealed selenium can 
reduce the occurrence of VAP in patients who mainly 
admitted in ICU due to trauma. Also their goal-
directed therapy didn’t change the mortality rate, 
significantly (26), while our supplementation resulted 
in reduction of mortality rate without significant 
effect on the incidence of VAP. Since VAP is the 
leading cause of death in the ICU, increases length of 
ICU and hospital stay and elevates mortality rate and 
costs, various treatments have been employed to 
reduce its incidence (27-29); however, in the present 
study, selenium supplementation did not affect VAP 
incidence.  
Up until now there is no conclusive 
investigation to show where the balance should lie 
between therapeutic and toxic doses of selenium (6, 
15). Therefore, the employed protocol of selenium 
administration can provide a useful insight about the 
required dose of this important trace element in the 
nutrition plan of patients with critical condition in our 
country. It is important to mention that our study was 
single-center trial that did not include patients from 
various geographical parts of Iran; therefore, it 
requires data of more centers to gain further validity. 
In addition, we did not measure selenium levels 
before and after the treatment, that is another 
limitation of the current investigation. 
Conclusion 
The obtained data of this single center clinical trial 
showed that selenium supplementation could improve 
clinical outcomes of critically ill patients.  
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